Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tamoxifen: Dr. Jekyll and Mr. Hyde?

Daniel F Hayes

    Journal of the National Cancer Institute
    |June 17, 2004
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same authorSame journal

    Recurrence Score® gene group components and outcomes in the RxPONDER trial (SWOG S1007).

    Journal of the National Cancer Institute·2026
    Same author

    Cognitive Impairment and Chemoendocrine vs Endocrine Therapy in Pre- and Postmenopausal Women: A Secondary Analysis of the RxPONDER Randomized Clinical Trial.

    JAMA oncology·2025
    Same author

    Novel Postneoadjuvant Prognostic Breast Cancer Staging System.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2025
    Same author

    Clinical Validity of Repeated Circulating Tumor Cell Enumeration as an Early Treatment Monitoring Tool for Metastatic Breast Cancer in the PREDICT Global Pooled Analysis.

    Clinical cancer research : an official journal of the American Association for Cancer Research·2025
    Same author

    Race and clinical outcomes in hormone receptor-positive, HER2-negative, node-positive breast cancer in the randomized RxPONDER trial.

    Journal of the National Cancer Institute·2024
    Same author

    Clinical and Genomic Risk for Late Breast Cancer Recurrence and Survival.

    NEJM evidence·2024